Vicore Pharma Holding AB (publ) (VCRE)
NASDAQ: VCRE · Real-Time Price · USD
9.09
+0.01 (0.11%)
At close: Oct 15, 2026, 4:00 PM EDT
9.19
+0.10 (1.10%)
After-hours: Oct 15, 2026, 4:04 PM EDT
Vicore Pharma Holding AB Stock Forecast
Stock Price Forecast
According to 2 analysts polled by S&P Global, Vicore Pharma Holding AB stock has a consensus rating of "Strong Buy" and an average price target of $29.16. The average 1-year stock price forecast is 220.79% higher than the current stock price, while the lowest is $25.08 (+175.91%) and the highest is $33.25 (+265.79%).
Price Target: $29.16 (+220.79%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Vicore Pharma Holding AB stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '26 | Aug '26 | Oct '26 |
|---|---|---|---|
| Strong Buy | 1 | 1 | 2 |
| Buy | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 |
| Total | 1 | 1 | 2 |
Financial Forecast
Revenue This Year
7.68M
from 3.82M
Increased by 101.29%
Revenue Next Year
44.65M
from 7.68M
Increased by 481.15%
EPS This Year
-1.86
from -1.99
EPS Next Year
-1.51
from -1.86
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is SEK.